Reliq Health Technologies, Inc. Announces Onboarding of New Mental Health Patients and Management Changes
25 Março 2024 - 8:43PM
Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or
WKN:A2AJTB) (“
Reliq” or the
“
Company”), a growing global healthcare technology
company that develops innovative Virtual Care solutions for the
multi-billion dollar Healthcare market, is pleased to announce that
it is adding the first five hundred patients to their expanded
mental health services portfolio and expects to add an additional
10,000 patients by the end of 2024.
“We are very pleased to be adding the first five
hundred patients in the US Virgin Islands, Florida and Nevada to
our new expanded mental health care program,” said Chris Shields,
CEO at Reliq Health Technologies, Inc. “Providing cognitive
assessments through iUGO Care will allow clinicians to identify and
treat patients with previously undiagnosed mental health needs.
Eligible patients will be provided with ongoing behavioral health
or collaborative care management services, for which their
physician will pay Reliq’s standard monthly subscription fees. In
addition, patients will receive cognitive assessments twice per
year for which their physician will pay Reliq a one-time fee per
assessment. The Company expects to generate an average revenue of
$576 per patient per year or $48 per patient per month for these
patients at 70% gross margin, and expects to add a further 10,000
new patients to our expanded mental health care program by the end
of 2024. The high demand for our new expanded mental health care
services further demonstrates our products’ unique ability to
address existing unmet needs in the Medicare patient population.
Our clients’ have consistently expressed high levels of
satisfaction with the usability and efficacy of our products, and
with the cost savings and new revenue streams they realize by
offering new services through our iUGO Care platform.”
The Company also wishes to announce that it has
accepted the resignation of its Chief Financial Officer, Michael
Frankel. Following the resignation of Mr. Frankel, the Board of
Directors has appointed Mr. Kevin Cornish as the Company’s Chief
Financial Officer.
“We are also delighted to announce the addition
of Kevin Cornish to the Reliq Management team as the Company’s
Chief Financial Officer,” continued Mr. Shields. “Mr. Cornish
possesses the critical skills and experience that will enable Reliq
to continue to grow its business in size and complexity. Mr.
Cornish is an accomplished public company CFO with over 17 years of
international leadership experience in finance, strategy and
operations. He has worked with multiple start-ups and led
successful turnarounds at a diverse group of companies in both
Canada and the United States. His experience with public company
audits and cross-border businesses will be a tremendous asset to
Reliq going forward. Mr. Cornish holds an MBA and a CPA
designation.”
About Reliq HealthReliq Health
Technologies is a growing global healthcare technology company that
specializes in developing innovative Virtual Care solutions for the
multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care
platform supports care coordination and community-based virtual
healthcare. iUGO Care allows complex patients to receive high
quality care at home, improving health outcomes, enhancing quality
of life for patients and families and reducing the cost of care
delivery. iUGO Care provides real-time access to remote patient
monitoring data, allowing for timely interventions by the care team
to prevent costly hospital readmissions and ER visits. Reliq Health
Technologies trades on the TSX Venture under the symbol RHT, on the
OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN:
A2AJTB.
ON BEHALF OF THE BOARD“Chris Shields”Interim CEO
For further information please contact:
Company ContactInvestor Relations at
ir@reliqhealth.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward
Looking InformationCertain statements in this press
release constitute forward-looking statements, within the meaning
of applicable securities laws. All statements that are not
historical facts, including without limitation, statements
regarding future estimates, plans, programs, forecasts,
projections, objectives, assumptions, expectations or beliefs of
future performance, are "forward-looking statements".
We caution you that such "forward-looking
statements" involve known and unknown risks and uncertainties that
could cause actual and future events to differ materially from
those anticipated in such statements.
Forward-looking statements include, but are not
limited to, statements with respect to commercial operations,
including technology development, anticipated revenues, projected
size of market, and other information that is based on forecasts of
future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the
"Company") does not intend and does not assume any
obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology
development and marketing activities, the Company's historical
experience with technology development, uninsured risks. Actual
results may differ materially from those expressed or implied by
such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies (TSXV:RHT)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Reliq Health Technologies (TSXV:RHT)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025